SOD2 and non-small cell lung carcinoma: Next-generation sequencing (NGS) has shown that NSCLC patients with BM have more copy number variations and alterations in genes encoding members of the cyclin-dependent kinase family, the SMAD family, and the superoxide dismutase 2 and PI3K signaling pathways compared with primary NSCLC patients 7,8.